| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/06/2002 | CN1338945A Combination of ileal bile acid transport inhibitors and bile acid sequestring agents for cardiovascular indications |
| 03/06/2002 | CN1338944A Cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| 03/06/2002 | CN1338943A Use of VEGF-C or VEGF-D gene or protein to prevent resitenosis |
| 03/06/2002 | CN1338942A Self-emulsifying compositions for drugs poorly soluble in water |
| 03/06/2002 | CN1338939A Compositions for the treatment of male erectile dysfunction |
| 03/06/2002 | CN1338938A Use of moxonidine for postmyocardial infarction treatment |
| 03/06/2002 | CN1338937A Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 03/06/2002 | CN1338936A Drug-combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 |
| 03/06/2002 | CN1338934A Mono-acyloxy aralkyl neuronuscular relaxants |
| 03/06/2002 | CN1338933A Methods and compositions to enhance white blood cell count |
| 03/06/2002 | CN1338932A Use of lipoic acid combination with ascorbic acid in the treatment of cancer |
| 03/06/2002 | CN1338931A Use of anticonvulsant derivatives for treating bulimia nervosa |
| 03/06/2002 | CN1338930A Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
| 03/06/2002 | CN1338929A Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 03/06/2002 | CN1338928A Combinations of formoterol and a tiotropium salt |
| 03/06/2002 | CN1338925A Enteric coated pharmaceutical tablet and method of manufacturing |
| 03/06/2002 | CN1338923A Method for controlling liposome size |
| 03/06/2002 | CN1338922A Use of nanoscale chitosanes and/or chitosane derivatives |
| 03/06/2002 | CN1338902A Smoking products containing antioxidants |
| 03/06/2002 | CN1338458A Ticlid acetylsalicylate, and its preparing process and medical application |
| 03/06/2002 | CN1338456A Benzodiazapine compounds containing imidazole propanamido and its preparing process and application |
| 03/06/2002 | CN1338454A Cyclic amino acid and cyclohydroxycarboxylic derivative substituted benzamidine derivatives and their uses as anticoagulants |
| 03/06/2002 | CN1338292A Liquid medicine for treating burn and scald |
| 03/06/2002 | CN1338290A Ointment for treating burn |
| 03/06/2002 | CN1338274A Powdered medicine 'Shaotangsan' for treating burn and scald |
| 03/06/2002 | CN1338270A Medicine for treating burn |
| 03/06/2002 | CN1338269A Medicine for treating cold and its preparing process |
| 03/06/2002 | CN1338259A White peony root's total glycoside injection |
| 03/06/2002 | CN1338258A Antibacterial clindamycin phosphate powder injection and its preparing process |
| 03/06/2002 | CN1338257A Cream for treating dermatopathy |
| 03/06/2002 | CN1338256A Anticancer compound and its application |
| 03/06/2002 | CN1338255A Oily gammariza injection |
| 03/06/2002 | CN1338254A Hydroxymethionine salt as trace element additive and its preparing process |
| 03/06/2002 | CN1338253A Method and medicinal composition for preventing and eliminating fish parasites |
| 03/06/2002 | CN1338251A Bactericidal composition |
| 03/06/2002 | CN1080267C Preparation of intermediat of 19, 11 beta-bridge steroid |
| 03/06/2002 | CN1080264C Oxathiolanes, method for their preparation and pharmaceutical compoistions containing same |
| 03/06/2002 | CN1080262C Novel substituted 4-(1H-benzimidazol-2-YL)[1,4] diazepanes useful for the treatment of allergic diseases |
| 03/06/2002 | CN1080261C 3-substituted 1-arylindole compounds |
| 03/06/2002 | CN1080260C Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 03/06/2002 | CN1080257C Guanidine derivatives |
| 03/06/2002 | CN1080125C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 03/06/2002 | CN1080122C Medicine for injury pain and its preparation |
| 03/06/2002 | CN1080121C Medicament for preventive and/or therapeutic treatment of hyperphosphatemia |
| 03/06/2002 | CN1080120C Pharmaceutical compositions |
| 03/06/2002 | CN1080119C Pharmaceutical composition contg. proton pump inhibitors |
| 03/06/2002 | CN1080118C Freeze-dried ondanstetron compositions |
| 03/06/2002 | CN1080117C Treamtent of tumors with compounds having RXR retinoid receptor agonist activity |
| 03/06/2002 | CN1080116C Use of medicinal feed for systemic treatment of fish diseases |
| 03/06/2002 | CN1080115C Elemi olefine injecta and its preparation |
| 03/06/2002 | CN1080113C Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 03/06/2002 | CA2356797A1 Combination treatment for depression and anxiety |
| 03/06/2002 | CA2356557A1 Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
| 03/06/2002 | CA2356545A1 Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
| 03/05/2002 | US6353363 Low voltage rail-to-rail CMOS output stage |
| 03/05/2002 | US6353128 For treatment of conditions such as septic shock. |
| 03/05/2002 | US6353124 Nonsteroidal antiinflammatory agents (aspirin, indomethacin, or ibuprofen) linked by tris amine or ethanolamine derivative to the acyl groups of fatty acids; improved transdermal delivery |
| 03/05/2002 | US6353117 Pyrazoline derivatives, their preparation and application as medicaments |
| 03/05/2002 | US6353116 Endothelin receptor antagonists |
| 03/05/2002 | US6353111 Which increase insulin secretion in the treatment of type ii diabetes; 2,3-di-substituted trans olefinic n-heteroaromatic or urido propionamides: the substitution at the 2-position being a substituted phenyl group and at the 3-position a |
| 03/05/2002 | US6353105 Inhibitors of 5-hydroxy-tryptamine reuptake of a monoamine transporter; analogs of cocaine; |
| 03/05/2002 | US6353103 Stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety. |
| 03/05/2002 | US6353055 Polycation homopolymer or copolymer |
| 03/05/2002 | US6353032 Wetting agents for eyes and stimulants of ocular mucin production |
| 03/05/2002 | US6353029 Storage stable tretinoin and 4-hydroxyanisole containing topical composition |
| 03/05/2002 | US6353028 Composition and method for topically treating Peyronie's Disease, Dupuytren's hand contracture, Ledderhose Fibrosis, erectile dysfunction arising from plaque accumulations, and scarring |
| 03/05/2002 | US6353026 Antiinflammatory agents with polymorphone neutrophils |
| 03/05/2002 | US6353025 Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same |
| 03/05/2002 | US6353024 Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias with trimebutine |
| 03/05/2002 | US6353023 Aromatic compounds with amide groups |
| 03/05/2002 | US6353022 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 03/05/2002 | US6353019 Anticancer drugs |
| 03/05/2002 | US6353018 Compounds, their preparation and use |
| 03/05/2002 | US6353016 Pyrrole compounds for potassium channel activators |
| 03/05/2002 | US6353015 Indole derivatives for nervous system disorders |
| 03/05/2002 | US6353014 Treatment of vision defects with prostaglandins |
| 03/05/2002 | US6353012 15-Hydroxyeicosatetraenoic acid-related compounds and methods of use |
| 03/05/2002 | US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents |
| 03/05/2002 | US6353009 Method for the treatment and prevention of hyperuricemia |
| 03/05/2002 | US6353008 Serotonin reuptake inhibitor as antidepressants |
| 03/05/2002 | US6353007 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 03/05/2002 | US6353006 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 03/05/2002 | US6353005 Treatment of gastrointestinal disorders |
| 03/05/2002 | US6353004 Peripherally acting anti-pruritic opiates |
| 03/05/2002 | US6353003 Method for reducing levels of homocysteine and C-reactive protein |
| 03/05/2002 | US6353002 Therapeutic agents |
| 03/05/2002 | US6353000 11-halo prostaglandins for the treatment of glaucoma or ocular hypertension |
| 03/05/2002 | US6352999 Drugs for nervous system disorders, parkinson's disease and antidepressants |
| 03/05/2002 | US6352998 A topical composition of a compound of the fk506 class in an alkanediol, ether diol, or diether alcohol solvent, an unsaturated fatty alcohol and water used as an antiinflammatory and antihyperproliferative for skin diseases |
| 03/05/2002 | US6352997 Oxoazasteroids for treatment of fertility problems and urogenital disorders |
| 03/05/2002 | US6352996 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 03/05/2002 | US6352995 Spiro-quinuclidine derivatives, their preparation and use |
| 03/05/2002 | US6352994 Nervous system disorders; psychological disorders |
| 03/05/2002 | US6352993 Pyrimidine derivatives and processes for the preparation thereof |
| 03/05/2002 | US6352992 Endothelin antagonist and beta receptor blocking agent as combined preparations |
| 03/05/2002 | US6352991 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents |
| 03/05/2002 | US6352990 CRF receptor antagonists and methods relating thereto |
| 03/05/2002 | US6352989 Nitrogenous heterocyclic derivatives and medicine thereof |
| 03/05/2002 | US6352988 High affinity for d4 receptors; treatment of schizophrenia, other psychoses, anxiety disorders, depression, alcohol abuse, impulse control disorders, aggression |
| 03/05/2002 | US6352987 Anorectic and antidiabetic agents |